2-methylacyl-CoA racemase deficiency is a very rare inherited metabolic disease. It happens when the body does not make enough working AMACR enzyme. This enzyme helps break down some branched fats and helps normal bile acid production. When the enzyme does not work well, harmful substances such as pristanic acid and unusual C27 bile acid intermediates can build up. This can injure the liver, nerves, brain, and eyes. Some people become sick in infancy with cholestasis and liver disease, while others first become sick much later with slowly worsening nerve and brain problems. The condition is usually inherited in an autosomal recessive pattern, which means a child receives one nonworking gene copy from each parent. [1][2][3][4]
2-Methylacyl-CoA racemase deficiency, also called alpha-methylacyl-CoA racemase deficiency or AMACR deficiency, is a very rare inherited metabolic disease. It happens when the body cannot properly use an enzyme called AMACR. This enzyme helps break down certain branched fats and helps make normal bile acids. When the enzyme does not work well, harmful substances such as pristanic acid and abnormal C27 bile acid intermediates can build up. Over time, this may injure the liver, eyes, brain, and nerves. The disease can start in infancy with cholestatic liver disease, or later in childhood or adult life with slow nerve and brain problems such as neuropathy, ataxia, vision trouble, seizures, migraine, and stroke-like episodes. Primary bile acid treatment with cholic acid is the main evidence-based therapy, and long-term diet control is also important.
Another names
Other names used for this disease include alpha-methylacyl-CoA racemase deficiency, AMACR deficiency, congenital bile acid synthesis defect type 4, bile acid synthesis defect congenital type 4, BAS defect type 4, BASD4, CBAS4, and intrahepatic cholestasis with defective conversion of trihydroxycoprostanic acid to cholic acid. Some sources also describe it as part of a liver disease-retinitis pigmentosa-polyneuropathy-epilepsy syndrome because those organs can all be involved. [1][2]
Types
-
Infantile or early-onset type. This form usually shows liver-related problems early in life, such as cholestasis, coagulopathy, fat-soluble vitamin deficiency, and sometimes severe liver disease. [2][3][5]
-
Adult or late-onset neurologic type. This form more often shows slowly progressive nerve and brain problems, such as neuropathy, seizures, ataxia, spasticity, cognitive decline, migraine, and abnormal brain MRI findings. [3][4][6][7]
-
Mixed or variable phenotype. Some patients and families show overlap. One person may mainly have liver disease, another may have neurologic disease, and another may be found by family screening with abnormal blood markers before major symptoms appear. [3][5]
Causes
The true root cause of this disease is usually one thing: biallelic disease-causing variants in the AMACR gene. Still, to match your request for 20 causes, the list below includes the main genetic cause plus the known disease mechanisms and factors that produce symptoms or make the disease more noticeable. [3][4]
-
Biallelic AMACR gene mutations. This is the main real cause. Both gene copies are affected, so the enzyme does not work properly. [3][4]
-
Autosomal recessive inheritance from carrier parents. Parents may be healthy carriers, but a child can inherit two altered copies. [3][4]
-
Loss of normal AMACR enzyme activity. Without enough enzyme activity, the body cannot properly process certain branched-chain fats and bile acid intermediates. [3][5]
-
Build-up of pristanic acid. This toxic fatty acid becomes markedly elevated and may damage nerves and other tissues. [3][5][6]
-
Build-up of DHCA. Dihydroxycholestanoic acid is an abnormal bile acid intermediate that rises because normal bile acid processing is blocked. [3][7]
-
Build-up of THCA. Trihydroxycholestanoic acid also rises and is an important biochemical clue to the disease. [3][7]
-
Defective bile acid synthesis. The body cannot make normal bile acids efficiently, which can cause cholestasis and poor fat absorption. [1][2][5]
-
Peroxisomal beta-oxidation block for specific substrates. The enzyme is needed so certain molecules can enter the correct form for breakdown inside peroxisomes. [3][5]
-
Abnormal stereoisomer conversion. AMACR normally changes R-forms to S-forms. Without that step, the body cannot clear these compounds well. [3]
-
Liver toxicity from abnormal bile intermediates. These abnormal compounds can injure liver cells and cause early liver disease. [1][2][5]
-
Nerve toxicity from accumulated branched fats. This may contribute to sensorimotor neuropathy, weakness, numbness, and gait problems. [4][6][8]
-
Brain involvement from toxic metabolite accumulation. This may lead to seizures, encephalopathy, cognitive decline, and white matter changes. [4][6][7][8]
-
Retinal injury. The retina can be affected, causing pigmentary retinopathy or retinal dysfunction even before major visual symptoms appear. [5][6]
-
Fat-soluble vitamin deficiency. Poor bile flow can reduce absorption of vitamins such as vitamin K and other fat-soluble vitamins, which can worsen symptoms. [5]
-
Vitamin K deficiency-related coagulopathy. In infants, bleeding tendency can appear because cholestasis reduces vitamin K absorption. [3][5]
-
High intake of phytanic or pristanic acid-containing foods may worsen metabolite load. Diet does not cause the genetic disease, but it may increase the burden of compounds the body already struggles to process. [3][6]
-
Poor compliance with low-phytanic/pristanic diet. This may allow abnormal metabolites to stay high. Again, it is not the root cause, but it can worsen biochemical imbalance. [3][6]
-
Family-related shared pathogenic variants. Some families show the same mutation in more than one sibling, but the severity can still differ a lot. [3]
-
Phenotypic heterogeneity. The same AMACR mutation can lead to early liver disease in one person and late neurologic disease in another. This is not a separate cause, but it explains why the disease looks different between patients. [3]
-
Delayed recognition of this rare disorder. Late diagnosis does not create the gene defect, but it can allow more damage to develop before treatment and dietary changes begin. [3][6][7]
Symptoms
-
Cholestatic jaundice. In infants, yellow skin and yellow eyes may appear because bile flow is reduced. [1][2][5]
-
Enlarged liver. Hepatomegaly can happen early and may be part of progressive liver disease. [2][3]
-
Easy bruising or bleeding. This can happen because vitamin K absorption is poor and blood clotting becomes abnormal. [3][5]
-
Poor fat absorption. Some patients have malabsorption because normal bile acids are needed to digest and absorb fats. [1][5]
-
Weakness in the arms or legs. Nerve involvement can cause weakness over time. [4][8]
-
Numbness or reduced feeling. Sensorimotor neuropathy may cause loss of sensation in the limbs. [4][8]
-
Gait difficulty. People may walk slowly, unsteadily, or feel that their legs are dragging. [6][7][8]
-
Ataxia. This means poor coordination and clumsy movement, often from cerebellar involvement. [4][6][7]
-
Spasticity. Muscles can become stiff and tight, especially in the legs. [4][6]
-
Seizures. Some patients develop seizures in early adulthood or later life. [3][4][6][8]
-
Episodes of encephalopathy. These are sudden periods of brain dysfunction that may look like confusion, reduced alertness, or stroke-like illness. [4][8]
-
Memory or thinking problems. Cognitive decline, concentration trouble, or slower thinking may occur. [4][6][7][8]
-
Vision problems. Retinal disease can cause visual decline, field loss, or retinitis pigmentosa-like findings. [4][5][6]
-
Tremor or shaking. Some adults develop hand tremor, head tremor, or voice tremor. [3][6]
-
Speech problems. Dysarthria can happen when brain or cerebellar pathways are affected. [6][7]
Diagnostic tests
Doctors do not rely on one test alone. They usually combine the story, physical examination, biochemical tests, genetic testing, and selected nerve, eye, and brain studies. The most important tests are the blood and urine tests that show abnormal pristanic acid and C27 bile acid intermediates, and then AMACR gene testing to confirm the diagnosis. [3][6][7][8]
Physical exam tests
-
General physical examination. The doctor looks for jaundice, poor growth, bruising, enlarged liver, or enlarged spleen, especially in infants and children. [2][3]
-
Neurologic examination. The doctor checks muscle tone, strength, reflexes, sensation, coordination, speech, and walking pattern because the disease often affects both central and peripheral nervous systems. [4][6]
-
Eye examination. A detailed eye exam can look for pigmentary retinopathy, retinal dysfunction, optic involvement, and other vision problems. [5][6]
-
Nutritional assessment. Clinicians check for signs of poor fat absorption and vitamin deficiency, because cholestasis may reduce absorption of fat-soluble vitamins. [5]
Manual tests
-
Gait assessment. Watching how the person walks can show ataxia, spastic gait, imbalance, or leg dragging. [6][7]
-
Finger-to-nose and heel-to-shin testing. These bedside coordination tests help show cerebellar ataxia and clumsy movement. [4][6][7]
-
Bedside sensory and reflex testing. Simple touch, vibration, pinprick, and tendon reflex checks can suggest peripheral neuropathy. [4][8]
Lab and pathological tests
-
Liver function tests. AST, ALT, bilirubin, and other liver markers can show liver injury or cholestasis. [3][4]
-
Coagulation studies. PT, INR, and related clotting tests help detect vitamin K deficiency-related coagulopathy. [3]
-
Serum pristanic acid level. This is one of the key tests because pristanic acid is often markedly increased. [3][6][7][8]
-
Serum phytanic acid level. Phytanic acid may be mildly elevated or sometimes normal, and it helps with differential diagnosis. [5][6][7][8]
-
Phytanic-to-pristanic acid ratio. A lower ratio with high pristanic acid can support AMACR deficiency. [6]
-
Plasma or urine bile acid profiling. Specialized analysis looks for abnormal C27 bile acid intermediates such as DHCA and THCA. [3][7][8]
-
Mass spectrometry-based metabolite testing. Tandem mass spectrometry or gas chromatography-mass spectrometry can help measure abnormal metabolites in blood, urine, or dried blood spots. [3][7][8]
-
Fat-soluble vitamin levels. These tests can show deficiency linked with cholestasis and malabsorption. [5]
-
Very-long-chain fatty acid testing. This is often done to help rule out other peroxisomal disorders; it may be normal in AMACR deficiency. [7][8]
-
AMACR gene testing. Molecular genetic testing confirms the diagnosis by finding disease-causing variants in AMACR. [2][3][6][8]
-
Liver biopsy or pathology in selected cases. This is not always required now, but it may show liver injury patterns such as giant cell hepatitis or help exclude other liver diseases. [5]
Electrodiagnostic tests
-
Nerve conduction studies and electromyography. These tests can show mild sensory or sensorimotor polyneuropathy, although some patients may have normal results. [6][7][8]
-
Electroencephalography or visual electrophysiology. EEG may help when seizures or encephalopathy are present, and retinal electrophysiology may detect retinal dysfunction even without obvious visual complaints. [5][6][8]
Imaging tests
- Brain MRI is one of the most helpful imaging studies in adults with neurologic symptoms. Reported findings include white matter hyperintensities and signal changes in areas such as the thalami, pons, midbrain, and other white matter regions. These findings are not unique to this disease, but they can strongly support the diagnosis when combined with the right blood tests. [4][6][7][8]
- A liver ultrasound may be used in infants or children with cholestasis to look at liver size and to exclude more common structural causes of jaundice. It does not confirm AMACR deficiency by itself, but it is often part of the real clinical workup. [2][5]
- Retinal imaging, such as optical coherence tomography and related ophthalmic imaging, may help detect retinal damage when vision is affected or when doctors suspect early retinal disease. It is especially useful because some patients can have retinal dysfunction even before they complain of poor vision. [5]
Non-pharmacological treatments
1. Low phytanic acid diet. This is one of the most important non-drug treatments. It aims to lower the amount of phytanic acid coming from food, because people with AMACR deficiency cannot process these fats well. Foods from ruminant animals and some fish are the main sources. The purpose is to reduce toxic fat build-up and lower future nerve and eye damage. The mechanism is simple: less harmful fat enters the body, so less accumulates in blood and tissues.
2. Low pristanic acid diet. Pristanic acid can also build up in AMACR deficiency and may contribute to neurologic disease. Restricting foods that increase pristanic acid load is often recommended by metabolic specialists. The purpose is to reduce metabolic stress and help control symptoms over time. The mechanism is decreased intake of the fat that the defective pathway cannot clear well.
3. Dietitian-led meal planning. A specialist dietitian helps the patient avoid risky foods while still getting enough calories, protein, vitamins, and minerals. The purpose is safety and long-term adherence. The mechanism is structured food choice, label reading, and balanced substitutes so the diet does not become too narrow.
4. Avoid fasting. Long fasting can push the body to release stored fats from body tissues. In related branched-fat disorders, this can raise circulating toxic fatty acids. The purpose is to avoid sudden metabolic worsening. The mechanism is preventing fat mobilization during starvation states.
5. Regular metabolic clinic follow-up. Patients need repeated review by a metabolic specialist. The purpose is early detection of liver injury, worsening neuropathy, balance problems, and vision changes. The mechanism is close monitoring and early adjustment of diet and treatment.
6. Liver function monitoring. Blood tests such as ALT, AST, bilirubin, and clotting tests help track liver health. The purpose is to catch inflammation, fibrosis, or liver failure early. The mechanism is surveillance, not direct healing, but it guides treatment quickly.
7. Eye monitoring. Retinal disease and visual dysfunction may happen even when the patient does not notice eye symptoms. The purpose is early diagnosis and support. The mechanism is serial eye exams and retinal testing.
8. Brain and nerve assessment. Neurology review, nerve conduction studies, and brain MRI are often used when symptoms appear. The purpose is to understand disease burden and follow progression. The mechanism is objective measurement of nerve and brain injury.
9. Physical therapy. This helps gait, balance, stiffness, muscle weakness, and endurance. The purpose is better mobility and lower fall risk. The mechanism is repeated guided movement that improves strength and function even when the genetic defect remains.
10. Occupational therapy. This helps with hand use, dressing, bathing, writing, and home adaptation. The purpose is independence. The mechanism is training in safer movement and use of tools or adaptive devices.
11. Speech and swallowing therapy. Some patients with neurologic disease develop speech difficulty or swallowing trouble. The purpose is safer eating and clearer communication. The mechanism is muscle training, swallowing strategies, and texture advice.
12. Vision rehabilitation. When retinal damage reduces vision, low-vision support can improve daily life. The purpose is function, not cure. The mechanism is magnifiers, contrast tools, and training to use remaining vision better.
13. Walking aids and orthotics. Canes, walkers, ankle-foot supports, or custom shoes may help neuropathy and ataxia. The purpose is stability and injury prevention. The mechanism is external support for weak or unsteady limbs.
14. Seizure safety planning. Patients with seizures need practical non-drug protection such as supervised bathing, avoiding driving when unsafe, and emergency planning. The purpose is injury prevention. The mechanism is reducing harm during sudden neurologic events.
15. Migraine trigger control. Some patients have migraine or migraine-like episodes. The purpose is fewer attacks. The mechanism is regular sleep, hydration, stress control, and trigger recognition.
16. Good sleep routine. Sleep helps brain health, pain control, and daily function. The purpose is symptom stability. The mechanism is reducing fatigue and improving brain recovery.
17. Psychological support. Living with a lifelong rare disease can cause anxiety, isolation, and stress. The purpose is emotional health and better treatment adherence. The mechanism is counseling, coping skills, and family support.
18. Genetic counseling. AMACR deficiency is usually autosomal recessive. The purpose is family planning and testing of relatives when appropriate. The mechanism is education about inheritance, risks, and options.
19. Family education. Families should learn signs of liver worsening, visual change, new weakness, altered behavior, and stroke-like episodes. The purpose is faster help-seeking. The mechanism is recognition of red-flag symptoms.
20. Long-term nutrition and vitamin review. Fat-soluble vitamin problems may happen in bile acid disorders. The purpose is to prevent secondary deficiency. The mechanism is planned nutrition review and replacement when tests show need.
Drug treatment
The main disease-targeted medicine is cholic acid. The FDA-approved product is Cholbam for bile acid synthesis disorders due to single enzyme defects. The label recommends 10 to 15 mg/kg by mouth once daily, preferably with food. Its purpose is to replace missing primary bile acids and suppress the body’s production of toxic abnormal bile acid intermediates. Its mechanism is negative feedback on bile acid synthesis, which lowers harmful precursor build-up and supports bile flow and digestion. Common side effects reported in the label include diarrhea, reflux esophagitis, malaise, jaundice, skin lesion, nausea, abdominal pain, intestinal polyp, urinary tract infection, and peripheral neuropathy. Liver tests must be monitored, because worsening liver impairment can occur.
Some specialists may also consider chenodeoxycholic acid in selected bile acid synthesis disorders, but the strongest FDA-labeled disease-specific approval here is for cholic acid, not for a large list of AMACR-specific drugs. In AMACR deficiency, other medicines are mostly supportive, meaning they treat symptoms rather than the enzyme defect itself. These may include anti-seizure drugs for seizures, medicines for neuropathic pain, drugs for muscle stiffness, reflux treatment, constipation treatment, and vitamin replacement. Exact choice and dose depend on age, liver status, pregnancy status, seizure type, and other diseases, so these are specialist decisions rather than one fixed disease recipe.
Dietary molecular supplements
There is no strong evidence that supplements cure AMACR deficiency, but some patients may need supplements when tests show deficiency or poor absorption. 1. Vitamin A may be needed if fat absorption is poor; it supports vision and immune barriers. 2. Vitamin D supports bone health. 3. Vitamin E supports nerve and cell membrane health. 4. Vitamin K supports normal blood clotting. 5. DHA or omega-3 support may be discussed for general nutrition, though not as a cure. 6. Multivitamin support may help restricted eaters. 7. Calcium may support bone health when dairy is reduced. 8. Iron may be used only if a real deficiency is present. 9. Folate may help if low intake exists. 10. B12 may be needed in selected patients with deficiency. These are supportive, not disease-correcting, and should be guided by blood tests and a specialist.
Immunity booster, regenerative, and stem-cell drugs
At present, there are no established immunity-booster drugs, regenerative drugs, or stem-cell drugs proven to reverse AMACR deficiency in routine clinical care. This matters because rare-disease articles sometimes overpromise. The honest evidence-based view is that current care focuses on bile acid replacement, diet control, and treatment of complications. Experimental future options may appear later, but they are not standard treatment now.
Surgeries
1. Liver transplantation may be considered in severe liver failure or cirrhosis that does not improve enough with medical treatment. The reason is to replace a failing liver and save life. 2. Cholecystectomy may be needed if symptomatic gallstones develop; the FDA label reports cholelithiasis in one patient on cholic acid. 3. Feeding tube placement can be considered in severe feeding or swallowing trouble. 4. Cataract or retinal-related eye procedures are not standard for AMACR itself but may be needed if separate eye complications arise. 5. Orthopedic procedures may sometimes be needed for severe contracture or deformity from chronic neurologic disability. These surgeries do not correct the genetic cause; they are done for complications.
Prevention ideas
Because AMACR deficiency is genetic, it cannot usually be fully prevented after conception. But complications can often be reduced. Good prevention steps include: early diagnosis, genetic counseling, newborn or early childhood testing when family history exists, starting bile acid therapy early when indicated, strict diet control, avoiding fasting, regular liver checks, regular eye and nerve checks, rapid treatment of new neurologic symptoms, and care by a metabolic specialist team. These steps may lower long-term damage even though they do not remove the gene change.
When to see a doctor
See a doctor quickly if there is jaundice, dark urine, pale stool, severe itching, new seizures, sudden confusion, new weakness, stroke-like symptoms, worsening balance, falling, vision decline, severe abdominal swelling, repeated vomiting, or bleeding/bruising. Regular specialist follow-up is also important even when symptoms seem stable, because liver and nerve injury may progress slowly and quietly.
What to eat and what to avoid
Helpful choices usually include fruits, vegetables, rice, bread, beans if tolerated, lean non-ruminant protein chosen by the dietitian, adequate water, balanced calories, prescribed vitamin support, and planned meals that avoid long fasting. Foods often limited or avoided are beef fat, lamb, full-fat dairy, butter, cheese, cream, goat or sheep milk fat, certain fish high in phytanic acid, foods with ruminant animal fat, and crash dieting or fasting. The exact list should be individualized with a metabolic dietitian.
FAQs
What is the main problem in this disease? The body cannot break down certain branched fats and cannot make bile acids normally.
Is it genetic? Yes. It is usually inherited in an autosomal recessive way.
Can babies get it? Yes. Some patients present in infancy with liver disease, while others present later with neurologic disease.
Can adults get symptoms first? Yes. Adult-onset neuropathy, ataxia, retinopathy, migraine, and stroke-like episodes are well described.
What is the main medicine? Cholic acid is the main evidence-based disease-targeted treatment.
Is there a cure? No established cure exists at present.
Does diet matter? Yes. Long-term restriction of phytanic and pristanic acid is important.
Can the eyes be affected? Yes. Retinal dysfunction and visual problems can occur.
Can the liver be affected? Yes. Liver fibrosis, cirrhosis, and severe cholestatic disease can occur.
Can seizures happen? Yes. Seizures are reported in some patients.
Can it cause nerve damage? Yes. Sensorimotor neuropathy is common in later-onset disease.
Are supplements enough? No. Supplements may support nutrition, but they do not correct the enzyme defect.
Are stem cells a proven treatment? No. Not in current standard care.
Can a liver transplant ever be needed? Yes, in severe progressive liver failure.
Why is early diagnosis important? Early diagnosis allows early diet treatment, monitoring, and bile acid therapy before more damage develops.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: March 12, 2025.
